Abstract | OBJECTIVE: METHODS: RESULTS:
Circulating tumor cells after the first cycle of chemotherapy correlated with tumor response after completion of chemotherapy (P = 0.012). Patients with brain as the first site suffered a higher rate of further metastases to other organs, and local recurrence, compared with those whose first site was the other organs (P < 0.001), and their survival rates were worse. Circulating tumor cells at baseline were the sole independent prognostic factor for specific progression-free survival. Receiver operating characteristic curves based on median specific progression-free survival revealed a circulating tumor cell cutoff at baseline of 218, and circulating tumor cells ≤218 at baseline correlated with significantly higher progression-free survival (P = 0.007), specific progression-free survival (P = 0.001) and overall survival (P = 0.001). CONCLUSIONS:
|
Authors | Lei Fu, Fang Liu, Hui Fu, Liqing Liu, Shuanghu Yuan, Yongsheng Gao, Zheng Fu, Jinming Yu |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 44
Issue 10
Pg. 948-55
(Oct 2014)
ISSN: 1465-3621 [Electronic] England |
PMID | 25135984
(Publication Type: Journal Article)
|
Copyright | © The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]. |
Topics |
- Aged
- Asian People
(statistics & numerical data)
- Brain Neoplasms
(epidemiology, prevention & control, secondary)
- Carcinoma, Small Cell
(epidemiology, prevention & control, secondary, therapy)
- Chemoradiotherapy
- China
(epidemiology)
- Cranial Irradiation
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms
(epidemiology, pathology, therapy)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(prevention & control)
- Neoplasm Staging
- Neoplastic Cells, Circulating
- Treatment Outcome
|